-
2
-
-
80355129623
-
Longterm outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies
-
Sorror ML, Sandmaier BM, Storer BE, Franke GN, Laport GG, Chauncey TR, et al. Longterm outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies. JAMA. 2011; 306(17): 1874-83.
-
(2011)
JAMA
, vol.306
, Issue.17
, pp. 1874-1883
-
-
Sorror, M.L.1
Sandmaier, B.M.2
Storer, B.E.3
Franke, G.N.4
Laport, G.G.5
Chauncey, T.R.6
-
3
-
-
75749124680
-
Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia
-
Lim Z, Brand R, Martino R, van Biezen A, Finke J, Bacigalupo A, et al. Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia. J Clin Oncol. 2010; 28 (3): 405-11.
-
(2010)
J Clin Oncol
, vol.28
, Issue.3
, pp. 405-411
-
-
Lim, Z.1
Brand, R.2
Martino, R.3
van Biezen, A.4
Finke, J.5
Bacigalupo, A.6
-
4
-
-
77951649470
-
Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome
-
McClune BL, Weisdorf DJ, Pedersen TL, Tunes da Silva G, Tallman MS, Sierra J, et al. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. J Clin Oncol. 2010; 28(11): 1878-87.
-
(2010)
J Clin Oncol
, vol.28
, Issue.11
, pp. 1878-1887
-
-
McClune, B.L.1
Weisdorf, D.J.2
Pedersen, T.L.3
Tunes da Silva, G.4
Tallman, M.S.5
Sierra, J.6
-
5
-
-
33846924515
-
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)
-
Estey E, de Lima M, Tibes R, Pierce S, Kantarjian H, Champlin R, et al. Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Blood. 2007; 109(4): 1395-400.
-
(2007)
Blood
, vol.109
, Issue.4
, pp. 1395-1400
-
-
Estey, E.1
de Lima, M.2
Tibes, R.3
Pierce, S.4
Kantarjian, H.5
Champlin, R.6
-
6
-
-
84870431609
-
Survival for older patients with acute myeloid leukemia: A population-based study
-
Oran B, Weisdorf DJ. Survival for older patients with acute myeloid leukemia: a population-based study. Haematologica. 2012; 97(12): 1916-24.
-
(2012)
Haematologica
, vol.97
, Issue.12
, pp. 1916-1924
-
-
Oran, B.1
Weisdorf, D.J.2
-
7
-
-
33750949551
-
Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: Problems and approaches
-
Deschler B, de Witte T, Mertelsmann R, Lubbert M. Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches. Haematologica. 2006; 91(11): 1513-22.
-
(2006)
Haematologica
, vol.91
, Issue.11
, pp. 1513-1522
-
-
Deschler, B.1
de Witte, T.2
Mertelsmann, R.3
Lubbert, M.4
-
8
-
-
31044436327
-
Comorbidity and beyond: Pretransplant clinical assessment
-
Artz AS. Comorbidity and beyond: pretransplant clinical assessment. Bone Marrow Transplant. 2005; 36(6): 473-4.
-
(2005)
Bone Marrow Transplant
, vol.36
, Issue.6
, pp. 473-474
-
-
Artz, A.S.1
-
9
-
-
42449142954
-
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation
-
Sorror M, Storer B, Sandmaier BM, Maloney DG, Chauncey TR, Langston A, et al. Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation. Cancer. 2008; 112(9): 1992-2001.
-
(2008)
Cancer
, vol.112
, Issue.9
, pp. 1992-2001
-
-
Sorror, M.1
Storer, B.2
Sandmaier, B.M.3
Maloney, D.G.4
Chauncey, T.R.5
Langston, A.6
-
10
-
-
23944440464
-
Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT
-
Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005; 106(8): 2912-9.
-
(2005)
Blood
, vol.106
, Issue.8
, pp. 2912-2919
-
-
Sorror, M.L.1
Maris, M.B.2
Storb, R.3
Baron, F.4
Sandmaier, B.M.5
Maloney, D.G.6
-
11
-
-
84865261103
-
Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: A prospective, multicenter GITMO study
-
Raimondi R, Tosetto A, Oneto R, Cavazzina R, Rodeghiero F, Bacigalupo A, et al. Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study. Blood. 2012; 120(6): 1327-33.
-
(2012)
Blood
, vol.120
, Issue.6
, pp. 1327-1333
-
-
Raimondi, R.1
Tosetto, A.2
Oneto, R.3
Cavazzina, R.4
Rodeghiero, F.5
Bacigalupo, A.6
-
12
-
-
84874754795
-
Predicting 10-year mortality for older adults
-
Cruz M, Covinsky K, Widera EW, StijacicCenzer I, Lee SJ. Predicting 10-year mortality for older adults. JAMA. 2013; 309(9): 874-6.
-
(2013)
JAMA
, vol.309
, Issue.9
, pp. 874-876
-
-
Cruz, M.1
Covinsky, K.2
Widera, E.W.3
StijacicCenzer, I.4
Lee, S.J.5
-
13
-
-
75749121075
-
Older breast cancer survivors: Geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up
-
Clough-Gorr KM, Stuck AE, Thwin SS, Silliman RA. Older breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up. J Clin Oncol. 2010; 28(3): 380-6.
-
(2010)
J Clin Oncol
, vol.28
, Issue.3
, pp. 380-386
-
-
Clough-Gorr, K.M.1
Stuck, A.E.2
Thwin, S.S.3
Silliman, R.A.4
-
14
-
-
80052704591
-
Predicting chemotherapy toxicity in older adults with cancer: A prospective multicenter study
-
Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011; 29(25): 3457-65.
-
(2011)
J Clin Oncol
, vol.29
, Issue.25
, pp. 3457-3465
-
-
Hurria, A.1
Togawa, K.2
Mohile, S.G.3
Owusu, C.4
Klepin, H.D.5
Gross, C.P.6
-
15
-
-
84863979585
-
Predictors of early death risk in older patients treated with first-line chemotherapy for cancer
-
Soubeyran P, Fonck M, Blanc-Bisson C, Blanc JF, Ceccaldi J, Mertens C, et al. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol. 2012; 30(15): 1829-34.
-
(2012)
J Clin Oncol
, vol.30
, Issue.15
, pp. 1829-1834
-
-
Soubeyran, P.1
Fonck, M.2
Blanc-Bisson, C.3
Blanc, J.F.4
Ceccaldi, J.5
Mertens, C.6
-
16
-
-
24044454968
-
Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)
-
Extermann M, Aapro M, Bernabei R, Cohen HJ, Droz JP, Lichtman S, et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005; 55(3): 241-52.
-
(2005)
Crit Rev Oncol Hematol
, vol.55
, Issue.3
, pp. 241-252
-
-
Extermann, M.1
Aapro, M.2
Bernabei, R.3
Cohen, H.J.4
Droz, J.P.5
Lichtman, S.6
-
17
-
-
84873728132
-
Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients
-
Muffly LS, Boulukos M, Swanson K, Kocherginsky M, Cerro PD, Schroeder L, et al. Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients. Biol Blood Marrow Transplant. 2013; 19(3): 429-34.
-
(2013)
Biol Blood Marrow Transplant
, vol.19
, Issue.3
, pp. 429-434
-
-
Muffly, L.S.1
Boulukos, M.2
Swanson, K.3
Kocherginsky, M.4
Cerro, P.D.5
Schroeder, L.6
-
18
-
-
0035383762
-
Hematopoietic cell transplantation in older patients with hematologic malignancies: Replacing high-dose cytotoxic therapy with graft-versus-tumor effects
-
McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood. 2001; 97(11): 3390-400.
-
(2001)
Blood
, vol.97
, Issue.11
, pp. 3390-3400
-
-
McSweeney, P.A.1
Niederwieser, D.2
Shizuru, J.A.3
Sandmaier, B.M.4
Molina, A.J.5
Maloney, D.G.6
-
19
-
-
0020396015
-
Toxicity and response criteria of the Eastern Cooperative Oncology Group
-
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982; 5(6): 649-55.
-
(1982)
Am J Clin Oncol
, vol.5
, Issue.6
, pp. 649-655
-
-
Oken, M.M.1
Creech, R.H.2
Tormey, D.C.3
Horton, J.4
Davis, T.E.5
McFadden, E.T.6
-
20
-
-
0014757443
-
Progress in development of the index of ADL
-
Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. The Gerontologist. 1970; 10(1): 20-30.
-
(1970)
The Gerontologist
, vol.10
, Issue.1
, pp. 20-30
-
-
Katz, S.1
Downs, T.D.2
Cash, H.R.3
Grotz, R.C.4
-
21
-
-
0014579432
-
Assessment of older people: Self-maintaining and instrumental activities of daily living
-
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969; 9(3): 179-86.
-
(1969)
Gerontologist
, vol.9
, Issue.3
, pp. 179-186
-
-
Lawton, M.P.1
Brody, E.M.2
-
22
-
-
0032212679
-
Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project
-
Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998; 51(11): 903-12.
-
(1998)
J Clin Epidemiol
, vol.51
, Issue.11
, pp. 903-912
-
-
Ware Jr., J.E.1
Gandek, B.2
-
23
-
-
2442699834
-
Frailty in older adults: Evidence for a phenotype
-
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56(3): M146-56.
-
(2001)
J Gerontol A Biol Sci Med Sci
, vol.56
, Issue.3
-
-
Fried, L.P.1
Tangen, C.M.2
Walston, J.3
Newman, A.B.4
Hirsch, C.5
Gottdiener, J.6
-
24
-
-
0026509066
-
Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale
-
Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res. 1992; 41(3): 237-48.
-
(1992)
Psychiatry Res
, vol.41
, Issue.3
, pp. 237-248
-
-
Miller, M.D.1
Paradis, C.F.2
Houck, P.R.3
Mazumdar, S.4
Stack, J.A.5
Rifai, A.H.6
-
25
-
-
0033134682
-
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
-
Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999; 106(5): 506-12.
-
(1999)
Am J Med
, vol.106
, Issue.5
, pp. 506-512
-
-
Harris, T.B.1
Ferrucci, L.2
Tracy, R.P.3
Corti, M.C.4
Wacholder, S.5
Ettinger Jr., W.H.6
-
26
-
-
53849093452
-
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation
-
Artz AS, Wickrema A, Dinner S, Godley LA, Kocherginsky M, Odenike O, et al. Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2008; 14(11): 1209-16.
-
(2008)
Biol Blood Marrow Transplant
, vol.14
, Issue.11
, pp. 1209-1216
-
-
Artz, A.S.1
Wickrema, A.2
Dinner, S.3
Godley, L.A.4
Kocherginsky, M.5
Odenike, O.6
-
27
-
-
41849122729
-
Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation
-
Fuji S, Kim SW, Fukuda T, Mori S, Yamasaki S, Morita-Hoshi Y, et al. Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2008; 14(5): 510-7.
-
(2008)
Biol Blood Marrow Transplant
, vol.14
, Issue.5
, pp. 510-517
-
-
Fuji, S.1
Kim, S.W.2
Fukuda, T.3
Mori, S.4
Yamasaki, S.5
Morita-Hoshi, Y.6
-
28
-
-
0019490358
-
The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire
-
Fillenbaum GG, Smyer MA. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol. 1981; 36(4): 428-34.
-
(1981)
J Gerontol
, vol.36
, Issue.4
, pp. 428-434
-
-
Fillenbaum, G.G.1
Smyer, M.A.2
-
29
-
-
84863304598
-
-
R Core Team, Vienna, Austria, R Foundation for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing
-
R Core Team. R: A language and environment for statistical computing. Vienna, Austria, R Foundation for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2012.
-
(2012)
R: A language and environment for statistical computing
-
-
-
30
-
-
83455259484
-
Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions
-
Liu H, Rich ES, Godley L, Odenike O, Joseph L, Marino S, et al. Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood. 2011; 118(24): 6438-45.
-
(2011)
Blood
, vol.118
, Issue.24
, pp. 6438-6445
-
-
Liu, H.1
Rich, E.S.2
Godley, L.3
Odenike, O.4
Joseph, L.5
Marino, S.6
-
31
-
-
63749116929
-
Fludarabine-melphalan conditioning for AML and MDS: Alemtuzumab reduces acute and chronic GVHD without affecting longterm outcomes
-
van Besien K, Kunavakkam R, Rondon G, De Lima M, Artz A, Oran B, et al. Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting longterm outcomes. Biol Blood Marrow Transplant. 2009; 15(5): 610-7.
-
(2009)
Biol Blood Marrow Transplant
, vol.15
, Issue.5
, pp. 610-617
-
-
van Besien, K.1
Kunavakkam, R.2
Rondon, G.3
De Lima, M.4
Artz, A.5
Oran, B.6
-
32
-
-
78650051826
-
Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: Reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease
-
O'Donnell PH, Artz AS, Undevia SD, Pai RK, Del Cerro P, Horowitz S, et al. Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease. Leuk Lymphoma. 51(12): 2240-9.
-
Leuk Lymphoma
, vol.51
, Issue.12
, pp. 2240-2249
-
-
O'Donnell, P.H.1
Artz, A.S.2
Undevia, S.D.3
Pai, R.K.4
Del Cerro, P.5
Horowitz, S.6
-
33
-
-
33747355260
-
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation
-
Artz AS, Pollyea DA, Kocherginsky M, Stock W, Rich E, Odenike O, et al. Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2006; 12(9): 954-64.
-
(2006)
Biol Blood Marrow Transplant
, vol.12
, Issue.9
, pp. 954-964
-
-
Artz, A.S.1
Pollyea, D.A.2
Kocherginsky, M.3
Stock, W.4
Rich, E.5
Odenike, O.6
-
34
-
-
84880422627
-
Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia
-
Klepin HD, Geiger AM, Tooze JA, Kritchevsky SB, Williamson JD, Pardee TS, et al. Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia. Blood. 2013; 121(21): 4287-94.
-
(2013)
Blood
, vol.121
, Issue.21
, pp. 4287-4294
-
-
Klepin, H.D.1
Geiger, A.M.2
Tooze, J.A.3
Kritchevsky, S.B.4
Williamson, J.D.5
Pardee, T.S.6
-
35
-
-
0035254219
-
Melphalan and purine analog-containing preparative regimens: Reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
-
Giralt S, Thall PF, Khouri I, Wang X, Braunschweig I, Ippolitti C, et al. Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood. 2001; 97(3): 631-7.
-
(2001)
Blood
, vol.97
, Issue.3
, pp. 631-637
-
-
Giralt, S.1
Thall, P.F.2
Khouri, I.3
Wang, X.4
Braunschweig, I.5
Ippolitti, C.6
-
36
-
-
55949099856
-
Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: A report from the cooperative German Transplant Study Group
-
Schetelig J, Bornhauser M, Schmid C, Hertenstein B, Schwerdtfeger R, Martin H, et al. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group. J Clin Oncol. 2008; 26(32): 5183-91.
-
(2008)
J Clin Oncol
, vol.26
, Issue.32
, pp. 5183-5191
-
-
Schetelig, J.1
Bornhauser, M.2
Schmid, C.3
Hertenstein, B.4
Schwerdtfeger, R.5
Martin, H.6
-
37
-
-
0036216138
-
Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons
-
Reuben DB, Cheh AI, Harris TB, Ferrucci L, Rowe JW, Tracy RP, et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc. 2002; 50(4): 638-44.
-
(2002)
J Am Geriatr Soc
, vol.50
, Issue.4
, pp. 638-644
-
-
Reuben, D.B.1
Cheh, A.I.2
Harris, T.B.3
Ferrucci, L.4
Rowe, J.W.5
Tracy, R.P.6
-
38
-
-
84862575323
-
Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score
-
Extermann M, Boler I, Reich RR, Lyman GH, Brown RH, DeFelice J, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012; 118(13): 3377-86.
-
(2012)
Cancer
, vol.118
, Issue.13
, pp. 3377-3386
-
-
Extermann, M.1
Boler, I.2
Reich, R.R.3
Lyman, G.H.4
Brown, R.H.5
DeFelice, J.6
-
39
-
-
79953836199
-
Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401
-
Hurria A, Cirrincione CT, Muss HB, Kornblith AB, Barry W, Artz AS, et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol. 2011; 29(10): 1290-6.
-
(2011)
J Clin Oncol
, vol.29
, Issue.10
, pp. 1290-1296
-
-
Hurria, A.1
Cirrincione, C.T.2
Muss, H.B.3
Kornblith, A.B.4
Barry, W.5
Artz, A.S.6
|